U
Nanomix Corporation
NNMX
$0.00
$0.000.00%
E
Sell
2/28/2023Downgrade
Nanomix Corporation (NNMX) was downgraded to E+ from D- on 2/28/2023 due to a decline in the volatility index.
Nanomix Corporation (NNMX) was downgraded to E+ from D- on 2/28/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
Nanomix Corporation (NNMX) was upgraded to D- from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
Nanomix Corporation (NNMX) was upgraded to D- from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
E
Sell
1/23/2023Downgrade
Nanomix Corporation (NNMX) was downgraded to E+ from D- on 1/23/2023 due to a decline in the volatility index.
Nanomix Corporation (NNMX) was downgraded to E+ from D- on 1/23/2023 due to a decline in the volatility index.
D
Sell
1/4/2023Upgraded
Nanomix Corporation (NNMX) was upgraded to D- from E+ on 1/4/2023 due to an increase in the volatility index and valuation index.
Nanomix Corporation (NNMX) was upgraded to D- from E+ on 1/4/2023 due to an increase in the volatility index and valuation index.
E
Sell
11/21/2022Downgrade
Nanomix Corporation (NNMX) was downgraded to E+ from D- on 11/21/2022 due to a noticeable decline in the growth index, solvency index and valuation index. EBIT declined 84.14% from -$1.6M to -$2.94M, earnings per share declined from -$0.0586 to -$0.08, and operating cash flow declined 35.7% from -$1.24M to -$1.68M.
Nanomix Corporation (NNMX) was downgraded to E+ from D- on 11/21/2022 due to a noticeable decline in the growth index, solvency index and valuation index. EBIT declined 84.14% from -$1.6M to -$2.94M, earnings per share declined from -$0.0586 to -$0.08, and operating cash flow declined 35.7% from -$1.24M to -$1.68M.
D
Sell
8/18/2022Upgraded
Nanomix Corporation (NNMX) was upgraded to D- from E+ on 8/18/2022 due to an increase in the valuation index.
Nanomix Corporation (NNMX) was upgraded to D- from E+ on 8/18/2022 due to an increase in the valuation index.
E
Sell
5/23/2022Downgrade
Nanomix Corporation (NNMX) was downgraded to E+ from D- on 5/23/2022 due to a substantial decline in the total return index and volatility index.
Nanomix Corporation (NNMX) was downgraded to E+ from D- on 5/23/2022 due to a substantial decline in the total return index and volatility index.
D
Sell
5/3/2022Downgrade
Nanomix Corporation (NNMX) was downgraded to D- from D on 5/3/2022 due to a decline in the volatility index and total return index.
Nanomix Corporation (NNMX) was downgraded to D- from D on 5/3/2022 due to a decline in the volatility index and total return index.
D
Sell
4/18/2022Upgraded
Nanomix Corporation (NNMX) was upgraded to D from D- on 4/18/2022 due to an increase in the valuation index and solvency index.
Nanomix Corporation (NNMX) was upgraded to D from D- on 4/18/2022 due to an increase in the valuation index and solvency index.
D
Sell
3/2/2022Upgraded
Nanomix Corporation (NNMXD) was upgraded to D- from E+ on 3/2/2022 due to a significant increase in the total return index.
Nanomix Corporation (NNMXD) was upgraded to D- from E+ on 3/2/2022 due to a significant increase in the total return index.
E
Sell
1/3/2022Upgraded
Nanomix Corporation (NNMX) was upgraded to E+ from E on 1/3/2022 due to a noticeable increase in the growth index and valuation index. Earnings per share increased from -$0.0039 to -$0.0027.
Nanomix Corporation (NNMX) was upgraded to E+ from E on 1/3/2022 due to a noticeable increase in the growth index and valuation index. Earnings per share increased from -$0.0039 to -$0.0027.
E
Sell
11/19/2021Upgraded
Nanomix Corporation (NNMX) was upgraded to E from E- on 11/19/2021 due to a noticeable increase in the volatility index.
Nanomix Corporation (NNMX) was upgraded to E from E- on 11/19/2021 due to a noticeable increase in the volatility index.
E
Sell
11/4/2021Downgrade
Boston Therapeutics, Inc. (BTHE) was downgraded to E- from E on 11/4/2021 due to a noticeable decline in the volatility index and valuation index.
Boston Therapeutics, Inc. (BTHE) was downgraded to E- from E on 11/4/2021 due to a noticeable decline in the volatility index and valuation index.
E
Sell
10/12/2021Upgraded
Boston Therapeutics, Inc. (BTHE) was upgraded to E from E- on 10/12/2021 due to a large increase in the volatility index.
Boston Therapeutics, Inc. (BTHE) was upgraded to E from E- on 10/12/2021 due to a large increase in the volatility index.
E
Sell
10/7/2021None
Nanomix Corporation (NNMX) was downgraded to E- from U on 10/07/2021.
Nanomix Corporation (NNMX) was downgraded to E- from U on 10/07/2021.
OTC PK
02/24/2025 2:42PM Eastern
Quotes delayed
